Wang, Peter Y.
Bartel, David P.
Funding for this research was provided by:
National Institutes of Health (GM118135)
Howard Hughes Medical Institute
Massachusetts Institute of Technology
Article History
Received: 18 February 2022
Accepted: 25 April 2023
First Online: 12 May 2023
Declarations
:
: Not applicable.
: Not applicable.
: D.P.B. has equity in Alnylam Pharmaceuticals, where he is a co-founder and advisor. P.Y.W. declares that he has no competing interests.